News &
Media
Stockhead: Neurotech shares soar 30% on US cannabis trial breakthrough
View More: Stockhead: Neurotech shares soar 30% on US cannabis trial breakthroughSmall Caps: Neurotech International Granted FDA Clearance for US Paediatric Study of NTI164
View More: Small Caps: Neurotech International Granted FDA Clearance for US Paediatric Study of NTI164Gold Coast Investment Showcase Presentation 2026
View More: Gold Coast Investment Showcase Presentation 2026Neurotech Investor & Advocacy Day
View More: Neurotech Investor & Advocacy DayCannabiz: Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial
View More: Cannabiz: Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trialNWR Virtual Healthcare Conference Presentation
View More: NWR Virtual Healthcare Conference PresentationHerald Sun: Could this new cannabis oil be a global first for treating autism?
View More: Herald Sun: Could this new cannabis oil be a global first for treating autism?Stockhead 2026 Health & Biotech Investor Guide
View More: Stockhead 2026 Health & Biotech Investor GuideStockhead: Neurotech partners with University of Sydney to advance Rett syndrome program
View More: Stockhead: Neurotech partners with University of Sydney to advance Rett syndrome program